FDA advisers back Cidara and Melinta’s antifungal treatment

A panel of outside experts convened by the Food and Drug Administration have recommended a new antifungal treatment developed by Cidara Therapeutics that could become the first therapy drug approved in more than a decade for candidemia and invasive candidiasis.